Netcall plc (NET)
London Exchange · UK · prices in GBX · close of 19 Oct 2026
Key indicators
| Last close | GBX 129.00 |
|---|---|
| 52-week range | 94.10 – 138.00 |
| Return, 1 month / 3 months | +4.5% / +8.4% |
| Return, 1 year / 3 years | +15.7% / +84.0% |
| Trend | Uptrend |
| RSI (14) | 82 |
| Volatility (1 year) | 26.0% |
| Worst drawdown (1 year) | -29.9% |
| Average daily value traded | 30.57M GBX |
| Dividend yield | 0.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Netcall plc is a software company based in the United Kingdom that supplies customer engagement and business process automation tools. Its products include a low-code application platform and cloud contact centre software, which help organisations manage customer interactions and streamline internal workflows. Customers come from both the private and public sectors, including service desks, local authorities and healthcare providers. The company focuses on helping these organisations improve how they handle enquiries and automate routine tasks.
Netcall plc trades under the code NET on the London Exchange in UK, with its price quoted in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Netcall plc (NET) trades on the London Exchange in UK. It last closed at GBX 129.00 on 19 October 2026.
Its price-based Market X-Ray is 67 out of 100 (a fair price profile), ranking 776 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 15.7% and over the last three months it rose 8.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 70 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 9.6% | ||
| From 52-week high | -5.8% | ||
| Momentum | 70 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 8.4% | ||
| 6-month return | 15.7% | ||
| 12-month return, skipping the last month | 10.7% | ||
| Stability (higher is calmer) | 60 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 26.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -29.9% | ||
| Liquidity | 81 · Strong | Trades actively. | |
| Average daily value traded | 30.57M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 45 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.0% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +1.6% |
|---|---|
| 1 month | +4.5% |
| 3 months | +8.4% |
| 6 months | +15.7% |
| 1 year | +15.7% |
| 3 years | +84.0% |
| 5 years | +62.4% |
Signals
| 50-day / 200-day average | 121.23 / 117.70 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.51 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 24 Dec 2026 | GBP 0.0110 |
| 29 Dec 2025 | GBP 0.0094 |
| 24 Dec 2024 | GBP 0.0089 |
| 28 Dec 2023 | GBP 0.0083 |
| 15 Dec 2022 | GBP 0.0054 |
| 23 Dec 2021 | GBP 0.0037 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.